Article
Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish.
Disease models & mechanisms - 1 Jan 2014
Valvezan Alexander J, Huang Jian, Lengner Christopher J, Pack Michael, Klein Peter S
Abstract excerpt
Truncating mutations in adenomatous polyposis coli (APC) are strongly linked to colorectal cancers. APC is a negative regulator of the Wnt pathway and constitutive Wnt activation mediated by enhanced Wnt-β-catenin target gene activation is believed to be the predominant mechanism responsible for APC mutant phenotypes. However, recent evidence suggests that additional downstream effectors contribute to APC mutant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
